[Topical steroid injection for refractory oral chronic graft-versus-host disease]

Rinsho Ketsueki. 2007 Nov;48(11):1508-10.
[Article in Japanese]

Abstract

The standard treatment for refractory oral chronic graft versus host disease (GVHD) has not been established. We present a case of AML accompanied by oral chronic GVHD in a 55-year-old man after allogeneic stem cell transplantation. The stomatitis of the patient was prolonged for a year and resistant to standard immunosuppressant therapy, including systemic administration of prednisolone and tacrolimus; however, local injection of 0.2% dexamethasone (0.5 mg per cm2) into the ulcerative area was drastically effective in improving refractory mucositis and mitigated a vicious cycle of mucosal damage and poor oral hygiene.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Chronic Disease
  • Dexamethasone / administration & dosage*
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Injections, Intralesional
  • Male
  • Middle Aged
  • Stem Cell Transplantation
  • Stomatitis / drug therapy*

Substances

  • Dexamethasone